NPR, July 21, 2014. No one likes it when a new drug in people’s medicine cabinets turns out to have problems — just remember the Vioxx debacle a decade ago, when the painkiller was removed from the market over concerns that it increased the risk of heart attack and stroke. To do a better job of spotting unforeseen risks and side effects, the Food and Drug Administration is trying something new — and there’s a decent chance that it involves your medical records.
Read More »News That Quotes Us & Our Work
We are often quoted in major newspapers and magazines, and on well-respected TV shows, radio programs, and websites where we share our opinion on issues that matter to you and your health. Stay up to date on health news and our take on it by reading the articles in this section.
Women’s Cancer Risk Raises Doubts About FDA Oversight
Wall Street Journal, July 8, 2014. A U.S. Food and Drug Administration database that catalogs medical-device problems holds thousands of entries on a tool called a laparoscopic power morcellator, used since the 1990s.
Read More »Faster Approval of New Medical Products Heightens Uncertainty Over Risks
AAAS, July 7, 2014. As new drugs and medical devices make their way through the FDA’s approval process at an accelerated rate, research on their safety and efficacy is not always as rigorous as it should be, experts cautioned at a AAAS event.
Read More »FDA OKs First-Ever DNA Alternative to Pap Smear
AP Health Writer, April 24, 2014. Federal health regulators have cleared a genetic test from Roche as a first-choice screening option for cervical cancer.
Read More »Alternative to Pap Test Is Approved by FDA
New York Times, April 24, 2014. The Food and Drug Administration on Thursday approved the first alternative to the long-used Pap test as a primary screening method for cervical cancer, in the face of opposition from some women’s groups and health organizations.
Read More »